A Multi-center Study of the Effect of Orthokeratology on Myopia Progression

A Prospective, Multi-center Study of the Effect of Orthokeratology on Myopia Progression in Chinese Children

This is a prospective study to validate an algorithm for predicting the effect of orthokeratology on myopia progression in children from 8 hospitals in China.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Orthokeratology (ortho-K) is thought to be an effective way to control the progression of Myopia in children, but its effectiveness may vary among different individuals. The investigators therefore conducted a prospective, multi-center study to use an algorithm to predict the progression of myopia among Chinese children wearing Orthokeratology lenses.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Anhui
      • Hefei, Anhui, China
        • Recruiting
        • Hefei Bright Eye Hospital
        • Contact:
          • Lijuan Wang, M.D
    • Guangdong
      • Guangzhou, Guangdong, China
        • Recruiting
        • Zhongshan Ophthalmic Center (Haizhu Branch), Sun Yat-sen University
        • Contact:
          • Xialin Liu, MD.
    • Hubei
      • Wuhan, Hubei, China
        • Recruiting
        • Wuhan Bright Eye hospital
        • Contact:
          • Shan Lin, M.D
    • Jiangxi
      • Nanchang, Jiangxi, China
        • Recruiting
        • Nanchang Bright Eye Hospital
        • Contact:
          • Yue Yan, M.D
    • Shandong
      • Jinan, Shandong, China
        • Recruiting
        • Jinan Bright Eye Hospital
        • Contact:
          • Ping Wang, M.D
    • Shanghai Province
      • Shanghai, Shanghai Province, China
        • Recruiting
        • Shanghai Bright Eye Hospital
        • Contact:
          • Yan Yan, M.D
    • Sichuan
      • Chengdu, Sichuan, China
        • Recruiting
        • Chengdu Bright Eye Hospital
        • Contact:
          • Min Cui, M.D
    • Yunnan
      • Kunming, Yunnan, China
        • Recruiting
        • Kunming Bright Eye hospital
        • Contact:
          • Xianghua Yuan, M.D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 15 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

1,000 children from 8 hospitals in China plan to wear orthokeratology lenses for myopia control.

Description

Inclusion Criteria:

  • -6.0D≤SER≤-0.5D
  • Astigmatism≤2.0D

Exclusion Criteria:

  • Contraindications of wearing Ortho-K.
  • Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.
  • Currently involved in other clinical studies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children with myopia

A total of 1,000 children from 8 hospitals in China is required to undergo ophthalmic examinations and complete questionnaires at baseline and

1yr after wearing ortho-k lenses.

Orthokeratology lenses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AUROC of the prediction algorithm for identifying fast progressing myopes
Time Frame: 1 year
Age-specific axial length (AL) changes previously described by Wang et al.(IOVS, 52 (11), 7949-53, 2011) are used as cut-off values to determine whether a child is a fast progressor or not. A child whose AL change falls on or above the cut-off value is considered to be a fast progressor.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity and specificity of the prediction algorithm for identifying fast progressing myopes
Time Frame: 1 year
The investigators will estimate sensitivity and specificity of the predictive algorithm for identifying fast progressing myopes.
1 year
Performance of an algorithm for predicting AL
Time Frame: 1 year
The investigators will use mean absolute error (MAE), R square to evaluate the performance.
1 year
Performance of an algorithm for predicting spherical equivalent refractive error
Time Frame: 1 year
The investigators will use mean absolute error (MAE), R square to evaluate the performance.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xialin Liu, M.D. Ph.D., Zhongshan Ophthalmic Center, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2020

Primary Completion (Anticipated)

March 1, 2021

Study Completion (Anticipated)

August 1, 2021

Study Registration Dates

First Submitted

February 21, 2020

First Submitted That Met QC Criteria

February 21, 2020

First Posted (Actual)

February 25, 2020

Study Record Updates

Last Update Posted (Actual)

February 28, 2020

Last Update Submitted That Met QC Criteria

February 26, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020KYPJ019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Orthokeratology lenses

3
Subscribe